Lynn Anne Bristol

Array ( [id] => 12606684 [patent_doc_number] => 20180094058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING TUMOR GROWTH AND TREATING CANCER BY TARGETING LECTIN GALACTOSIDE-BINDING SOLUBLE 3 BINDING PROTEIN [patent_app_type] => utility [patent_app_number] => 15/567251 [patent_app_country] => US [patent_app_date] => 2016-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122062 [patent_doc_number] => 20160319036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'MULTISPECIFIC DOMAIN EXCHANGED COMMON VARIABLE LIGHT CHAIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/092847 [patent_app_country] => US [patent_app_date] => 2016-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22393 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15363613 [patent_doc_number] => 20200017571 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-01-16 [patent_title] => TNFRSF14 / HVEM PROTEINS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/563666 [patent_app_country] => US [patent_app_date] => 2016-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -185 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15363613 [patent_doc_number] => 20200017571 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-01-16 [patent_title] => TNFRSF14 / HVEM PROTEINS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/563666 [patent_app_country] => US [patent_app_date] => 2016-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -185 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003874 [patent_doc_number] => 20160200823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/084088 [patent_app_country] => US [patent_app_date] => 2016-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 45274 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15084088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075737 [patent_doc_number] => 20160272701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/082541 [patent_app_country] => US [patent_app_date] => 2016-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24445 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12680995 [patent_doc_number] => 20180118831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => CAR T-CELLS FOR THE TREATMENT OF B7-H4 EXPRESSING SOLID TUMORS [patent_app_type] => utility [patent_app_number] => 15/561968 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -61 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12702310 [patent_doc_number] => 20180125936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => METHOD OF TREATING NEOPLASIAS [patent_app_type] => utility [patent_app_number] => 15/564183 [patent_app_country] => US [patent_app_date] => 2016-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20653 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059602 [patent_doc_number] => 20160256563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/071146 [patent_app_country] => US [patent_app_date] => 2016-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 38453 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12205858 [patent_doc_number] => 20180051084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'COMBINATION OF BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND CHECK POINT INHIBITORS FOR IMPROVED EFFICACY AGAINST CANCER' [patent_app_type] => utility [patent_app_number] => 15/557211 [patent_app_country] => US [patent_app_date] => 2016-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2964 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11078274 [patent_doc_number] => 20160275238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'METHOD FOR IMPROVING ANTIBODY STABILITY' [patent_app_type] => utility [patent_app_number] => 15/061130 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13832 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12185468 [patent_doc_number] => 20180044404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/555951 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 31244 [patent_no_of_claims] => 172 [patent_no_of_ind_claims] => 62 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11054481 [patent_doc_number] => 20160251443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/058738 [patent_app_country] => US [patent_app_date] => 2016-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 81328 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421357 [patent_doc_number] => 20170029501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 15/053964 [patent_app_country] => US [patent_app_date] => 2016-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 45037 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15053964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11047569 [patent_doc_number] => 20160244528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'ANTIBODY THERAPEUTICS THAT BIND CD137' [patent_app_type] => utility [patent_app_number] => 15/049718 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33452 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15049718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471258 [patent_doc_number] => 20170058042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'ANTI-Ly6E ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/018710 [patent_app_country] => US [patent_app_date] => 2016-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26840 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15978083 [patent_doc_number] => 10669350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy [patent_app_type] => utility [patent_app_number] => 15/543215 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 29 [patent_no_of_words] => 16003 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12428373 [patent_doc_number] => 09975965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Compositions and methods for treatment and detection of cancers [patent_app_type] => utility [patent_app_number] => 15/011543 [patent_app_country] => US [patent_app_date] => 2016-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 87 [patent_no_of_words] => 53572 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15011543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209225 [patent_doc_number] => 10118969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Compositions and methods relating to universal glycoforms for enhanced antibody efficacy [patent_app_type] => utility [patent_app_number] => 15/011544 [patent_app_country] => US [patent_app_date] => 2016-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 61728 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15011544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11568866 [patent_doc_number] => 20170107509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'SURFACE DISPLAY OF WHOLE ANTIBODIES IN EUKARYOTES' [patent_app_type] => utility [patent_app_number] => 15/007622 [patent_app_country] => US [patent_app_date] => 2016-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29336 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007622 [rel_patent_id] =>[rel_patent_doc_number] =>)